About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Haemophilia
›
Top Articles
Haemophilia
2.6
(top 20%)
impact factor
5.6K
(top 5%)
papers
115.0K
(top 5%)
citations
110
(top 5%)
h
-index
2.7
(top 20%)
impact factor
6.6K
all documents
120.4K
doc citations
160
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Guidelines for the management of hemophilia
Haemophilia
2013
1,538
2
WFH Guidelines for the Management of Hemophilia, 3rd edition
Haemophilia
2020
915
3
von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)
1
Haemophilia
2008
815
4
The epidemiology of inhibitors in haemophilia A: a systematic review
Haemophilia
2003
538
5
The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation
Haemophilia
2004
516
6
Inherited antithrombin deficiency: a review
Haemophilia
2008
325
7
Range of motion measurements: reference values and a database for comparison studies
Haemophilia
2011
293
8
Hemophilia joint health score reliability study
Haemophilia
2006
273
9
The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization
Haemophilia
2006
267
10
Optimizing outcomes for patients with severe haemophilia A
Haemophilia
2007
235
11
Pathogenesis of haemophilic arthropathy
Haemophilia
2006
233
12
Normal range of bleeding scores for the ISTH‐BAT: adult and pediatric data from the merging project
Haemophilia
2014
230
13
Genetic risk factors for inhibitors to factors VIII and IX
Haemophilia
2006
229
14
International workshop on immune tolerance induction: consensus recommendations
Haemophilia
2007
228
15
Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia
Haemophilia
2010
226
16
A study of variations in the reported haemophilia A prevalence around the world
Haemophilia
2010
224
17
Rare coagulation deficiencies
Haemophilia
2002
215
18
Clinical severity of haemophilia A: does the classification of the 1950s still stand?
Haemophilia
2011
212
19
Safety of factor VIII inhibitor bypass activity (FEIBA® ): 10-year compilation of thrombotic adverse events
Haemophilia
2002
206
20
Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders
Haemophilia
2008
206
21
Barriers to compliance with prophylaxis therapy in haemophilia
Haemophilia
2001
203
22
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors
Haemophilia
1998
201
23
Rare inherited disorders of fibrinogen
Haemophilia
2008
197
24
Clinical diagnosis of von Willebrand disease
Haemophilia
2004
196
25
The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development
Haemophilia
2001
193
26
Venous access in haemophilic children: choice and management
Haemophilia
2010
193
27
European Study on Orthopaedic Status of haemophilia patients with inhibitors
Haemophilia
2007
192
28
European principles of haemophilia care
Haemophilia
2008
191
29
Incidence of inhibitors in haemophilia A patients - a review of recent studies of recombinant and plasma-derived factor VIII concentrates
Haemophilia
1999
190
30
Consensus perspectives on prophylactic therapy for haemophilia: summary statement
Haemophilia
2003
190
31
Nanofiltration of plasma-derived biopharmaceutical products
Haemophilia
2003
185
32
Factor XIII deficiency
Haemophilia
2008
184
33
Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome
Haemophilia
2002
182
34
Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey
Haemophilia
2000
179
35
Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels
Haemophilia
2011
174
36
Pregnancy complications and obstetric care in women with inherited bleeding disorders
Haemophilia
2013
173
37
Assessing health-related quality-of-life in individuals with haemophilia
Haemophilia
1999
171
38
Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia
Haemophilia
2011
170
39
Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy
Haemophilia
2006
169
40
Protein C deficiency
Haemophilia
2008
169
41
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients
Haemophilia
2002
168
42
More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders
Haemophilia
2005
166
43
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A
Haemophilia
2003
165
44
FEIBAR: mode of action
Haemophilia
2004
165
45
The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization
Haemophilia
2004
164
46
Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry
Haemophilia
2005
163
47
Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A
Haemophilia
2007
160
48
Pharmacokinetics of activated recombinant coagulation factor VII (NovoSevenR) in children vs. adults with haemophilia A
Haemophilia
2004
158
49
Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL)
Haemophilia
2004
157
50
Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene
Haemophilia
2006
157
site/software ©
exaly
; All materials licenced under
CC by-SA
.